Back
uniQure NV 10K Form
Sell
46
QURE
uniQure NV
Last Price:
$17.13
Seasonality Move:
3.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive QURE News And Ratings
See the #1 stock for the next 7 days that we like better than QURE
QURE Financial Statistics
Sales & Book Value
| Annual Sales: | $16.1M |
|---|---|
| Cash Flow: | $-78.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.19 |
| Price / Book: | 5.47 |
Profitability
| EPS (TTM): | -3.48090 |
|---|---|
| Net Income (TTM): | $-199M |
| Gross Margin: | $-347K |
| Return on Equity: | -220.8% |
| Return on Assets: | -28.75% |
uniQure NV Earnings Forecast
Key uniQure NV Financial Ratios
-
The Gross Profit Margin over the past 16 years for QURE is -2.16%.
-
The Selling, General & Administrative Expenses for QURE have been equal to 406.61% of Gross Profit Margin.
-
The Research & Development expenses have been 835.05% of Revenue.
-
The Net Earning history of QURE is -1,236.00% of Total Revenues.
-
Per Share Earnings over the last 16 years have been positive in 7 years.
uniQure NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | QURE |
| CUSIP: | N90064 |
| Website: | uniqure.com |
Debt
| Debt-to-Equity Ratio: | 2.7 |
|---|---|
| Current Ratio: | 10.43 |
| Quick Ratio: | 9.99 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
QURE Technical Analysis vs Fundamental Analysis
Sell
46
uniQure NV (QURE)
is a Sell
Is uniQure NV a Buy or a Sell?
-
uniQure NV stock is rated a SellThe current uniQure NV [QURE] share price is $17.16. The Score for QURE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.